Difference between revisions of "Section 3: Diagnosis and treatment of SARS-CoV-2 infected patients (from DOI: 10.1080/22221751.2020.1735265) (Q8399)"
Jump to navigation
Jump to search
(Created claim: Has Sectioning (P146): Section 3.5.6: Empirical antimicrobial therapy (from DOI: 10.1080/22221751.2020.1735265) (Q8416), #quickstatements; #temporary_batch_1589488703697) |
(Created claim: Has Sectioning (P146): Section 5: Criteria of isolation release and discharge (from DOI: 10.1080/22221751.2020.1735265) (Q8418), #quickstatements; #temporary_batch_1589488703697) |
||
(One intermediate revision by the same user not shown) | |||
Property / Has Sectioning | |||
+ | |||
Property / Has Sectioning: Section 4: Protection and transfer (from DOI: 10.1080/22221751.2020.1735265) / rank | |||
+ | Normal rank | ||
Property / Has Sectioning | |||
+ | |||
Property / Has Sectioning: Section 5: Criteria of isolation release and discharge (from DOI: 10.1080/22221751.2020.1735265) / rank | |||
+ | Normal rank |
Latest revision as of 20:41, 14 May 2020
Publication: "Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection" in the journal Emerg Microbes Infect (2020); DOI: 10.1080/22221751.2020.1735265
Language | Label | Description | Also known as |
---|---|---|---|
English |
Section 3: Diagnosis and treatment of SARS-CoV-2 infected patients (from DOI: 10.1080/22221751.2020.1735265)
|
Publication: "Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection" in the journal Emerg Microbes Infect (2020); DOI: 10.1080/22221751.2020.1735265
|
Statements
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references